Sponsor franchise
eFFECTOR Therapeutics
Named principals: Brian G. Atwood, Chris Ehrlich
Grouping established from the sponsor entity and issuer names.
Vehicles launched
2
0 still live
Capital raised
$344M
aggregate IPO proceeds
Trust under management
—
in live vehicles
Deals closed
2
0 liquidated
Completion rate
100%
of 2 resolved
Vehicles
Every SPAC attributed to eFFECTOR Therapeutics, newest IPO first.
- Completed
- Trust
- $175M
- Per share
- $10.18
- IPO
- Jan 2021
- Deadline
- —